Sweden will step up insurance checks on foreign ships as worries about Russia rise
STOCKHOLM — Sweden said Saturday it will step up insurance checks on foreign ships in a move aimed at tightening controls on Russia's so-called "shadow fleet ' of aging ships.
The government in Stockholm said that, starting July 1, the coast guard and the Swedish Maritime Administration will be tasked with collecting insurance information not just from ships that call at Swedish ports, but also those that pass through the country's territorial waters and exclusive economic zone.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
2 rescued after plane crashes into ocean off coast of Connecticut
BRANFORD, Conn. (WTNH) — Two people were rescued after a plane crashed into the ocean off the coast of Connecticut Sunday morning, according to officials. The Federal Aviation Administration (FAA) said around 10:30 a.m., a Piper PA-32 Cherokee with two occupants crashed into the Long Island Sound, not far from Tweed New Haven Airport. Tweed officials said the plane was traveling from Bridgeport, Conn., to an undisclosed location. The plane was diverted to Tweed for an emergency landing about eight miles away from the airport. A crew from the Coast Guard station in New Haven arrived on the scene first, followed by first responders from nearby towns including Branford, Guilford, and West Haven. By the time rescue crews from other areas responded to the scene, the plane had fully submerged into the Long Island Sound, according to the Branford Fire Department. Fire officials said the pilot was able to send his coordinates before the plane sank. A representative from the Coast Guard told Nexstar that the plane's two occupants had managed to get out of the plane before crews arrived. They were rescued from the water, wearing life jackets, and were transported to the care of medical crews. They were treated for minor injuries and hypothermia, and were taken to a nearby hospital for additional care, the Coast Guard said. 'We are deeply relieved that both individuals were safely recovered and extend our sincere gratitude to all federal, state, and local responders for their swift and coordinated response,' reads a message posted to Facebook from airport officials with Tweed. The FAA is investigating. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
15 hours ago
- Yahoo
Biomarker Data from Alligator Bioscience's OPTIMIZE-1 Trial Presented at ASCO 2025 Annual Meeting
LUND, SE / / June 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced that biomarker data from its OPTIMIZE-1 clinical trial were presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. OPTIMIZE-1 is a Phase 1b/2 trial evaluating mitazalimab in combination with mFOLFIRINOX in first-line metastatic pancreatic cancer (mPDAC). The study has demonstrated strong clinical outcomes to date, including a ~30% survival rate at 24 months and a median overall survival of 14.9 months. The biomarker analyses highlighted mitazalimab's immunological mechanism of action, with immune activation in responding patients and gene signatures associated with clinical benefit and improved survival. These results support continued development of mitazalimab, including a planned confirmatory trial in mPDAC. "ASCO continues to be a cornerstone event for clinical oncology, and it was a privilege to share our OPTIMIZE-1 data with the international community," said Søren Bregenholt, CEO of Alligator Bioscience. "The high level of engagement and many productive meetings we've had during the conference further validate the growing interest in mitazalimab and its potential in pancreatic cancer." The presentation poster is available on Alligator's website . Alligator's participation at ASCO is part of its broader commitment to scientific collaboration and strategic business development. For further information, please contact: Søren Bregenholt, CEOE-mail: +46 (0) 46 540 82 00 The information was submitted for publication, through the agency of the contact person set out above, at 8:45 a.m. CEST on 3 June 2025. About Alligator Bioscience Alligator is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. This validated approach promotes priming of tumor-specific T cells and reversing the immunosuppressive nature of the tumor microenvironment, with significant potential benefits for cancer patients across multiple types of cancer. The Company's lead drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 24-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1. Alligator is listed on Nasdaq Stockholm (ATORX) and headquartered in Lund, Sweden. For more information, please visit . Attachments Biomarker data from Alligator Bioscience's OPTIMIZE-1 trial presented at ASCO 2025 Annual Meeting SOURCE: Alligator Bioscience View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
17 hours ago
- Bloomberg
Klarna CEO Attracts Sweden's Elite in Flat Capital Share Sale
Flat Capital AB, the investment firm of Klarna co-founder Sebastian Siemiatkowski and his wife Nina Siemiatkowski, has broadened its shareholder base via a rights issue that included some of Sweden's most prominent business families. About three-quarters of the 300 million Swedish-krona ($31.4 million) rights issue has been secured by existing owners and new investors, according to a statement late on Monday.
